Curaleaf (OTCMKTS:CURLF) Trading Down 6.6% – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) was down 6.6% during trading on Monday . The company traded as low as $2.44 and last traded at $2.4480. Approximately 434,551 shares were traded during trading, a decline of 30% from the average daily volume of 619,210 shares. The stock had previously closed at $2.62.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Atb Cap Markets upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 2nd. Zacks Research raised shares of Curaleaf from a “strong sell” rating to a “hold” rating in a research report on Thursday. ATB Capital upgraded shares of Curaleaf to an “outperform” rating in a research note on Tuesday, December 2nd. Canaccord Genuity Group upgraded shares of Curaleaf to a “strong-buy” rating in a research report on Thursday, October 9th. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Curaleaf in a research report on Monday, December 22nd. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Curaleaf Trading Down 5.3%

The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of -7.76 and a beta of 0.73. The company has a fifty day moving average price of $2.69 and a 200-day moving average price of $2.37. The company has a current ratio of 1.47, a quick ratio of 0.71 and a debt-to-equity ratio of 0.96.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.57%. On average, equities research analysts predict that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.